Correlation Between Nautilus Biotechnology and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nautilus Biotechnology and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nautilus Biotechnology and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nautilus Biotechnology and Olema Pharmaceuticals, you can compare the effects of market volatilities on Nautilus Biotechnology and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nautilus Biotechnology with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nautilus Biotechnology and Olema Pharmaceuticals.
Diversification Opportunities for Nautilus Biotechnology and Olema Pharmaceuticals
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Nautilus and Olema is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Nautilus Biotechnology and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and Nautilus Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nautilus Biotechnology are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of Nautilus Biotechnology i.e., Nautilus Biotechnology and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nautilus Biotechnology and Olema Pharmaceuticals
Given the investment horizon of 90 days Nautilus Biotechnology is expected to under-perform the Olema Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Nautilus Biotechnology is 1.33 times less risky than Olema Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Olema Pharmaceuticals is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 1,153 in Olema Pharmaceuticals on September 1, 2024 and sell it today you would lose (141.00) from holding Olema Pharmaceuticals or give up 12.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nautilus Biotechnology vs. Olema Pharmaceuticals
Performance |
| Timeline |
| Nautilus Biotechnology |
| Olema Pharmaceuticals |
Nautilus Biotechnology and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nautilus Biotechnology and Olema Pharmaceuticals
The main advantage of trading using opposite Nautilus Biotechnology and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nautilus Biotechnology position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| Nautilus Biotechnology vs. C4 Therapeutics | Nautilus Biotechnology vs. Kymera Therapeutics | Nautilus Biotechnology vs. Foghorn Therapeutics | Nautilus Biotechnology vs. Revolution Medicines |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |